|
Aplastic Anemia & MDS International Foundation: Bone Marrow Failure Disease Scientific Symposium 2014
|
Jan 2015
|
Leuk Res
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Historical perspectives on myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
|
Aug 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed
|
Dec 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
|
Feb 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Good riddance to the term "refractory anemia" in myelodysplastic syndromes
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
